Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...
The APPA, if passed into law, puts an upper limit of 20 patents, but only of certain types of patents (see below), that can be asserted in a BPCIA litigation (the APPA does not affect ANDA litigations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback